14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $4.71 $5.77 Friday, 3rd May 2024 AUPH stock ended at $5.10. This is 1.35% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 8.94% from a day low at $5.09 to a day high of $5.55.
90 days $4.71 $8.49
52 weeks $4.71 $12.42

Historical Aurinia Pharmaceuticals Inc prices

Date Open High Low Close Volume
Dec 13, 2021 $20.10 $20.21 $19.28 $19.90 3 319 961
Dec 10, 2021 $21.57 $21.90 $20.07 $20.13 4 505 771
Dec 09, 2021 $21.60 $22.15 $20.85 $20.97 7 996 137
Dec 08, 2021 $20.13 $21.13 $18.71 $20.83 2 755 136
Dec 07, 2021 $19.15 $20.86 $19.15 $20.21 3 003 204
Dec 06, 2021 $18.51 $19.33 $17.30 $19.15 3 073 629
Dec 03, 2021 $21.04 $21.24 $18.40 $18.67 6 661 140
Dec 02, 2021 $18.65 $21.02 $18.43 $20.14 12 843 661
Dec 01, 2021 $18.80 $19.31 $17.68 $17.78 2 787 654
Nov 30, 2021 $18.50 $19.01 $17.41 $18.84 3 321 011
Nov 29, 2021 $19.55 $19.80 $17.85 $18.34 4 172 535
Nov 26, 2021 $19.47 $20.20 $19.20 $19.33 2 118 613
Nov 24, 2021 $19.50 $20.27 $19.05 $19.71 2 962 970
Nov 23, 2021 $19.67 $20.41 $17.30 $19.36 9 960 830
Nov 22, 2021 $24.46 $24.55 $19.50 $19.65 21 341 193
Nov 19, 2021 $29.40 $29.92 $28.20 $28.47 2 181 903
Nov 18, 2021 $29.00 $30.44 $28.82 $29.66 2 755 662
Nov 17, 2021 $28.35 $29.78 $27.37 $29.20 3 368 235
Nov 16, 2021 $26.65 $28.50 $26.24 $27.55 3 806 148
Nov 15, 2021 $29.31 $29.70 $26.78 $27.03 5 511 745
Nov 12, 2021 $29.14 $30.20 $28.21 $29.76 2 310 153
Nov 11, 2021 $29.90 $30.00 $28.13 $28.90 2 671 025
Nov 10, 2021 $30.50 $31.69 $29.46 $29.62 3 200 762
Nov 09, 2021 $31.25 $31.34 $29.76 $30.06 3 043 060
Nov 08, 2021 $31.57 $32.49 $31.05 $31.32 2 998 907
Click to get the best stock tips daily for free!

About Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.... AUPH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT